| |
|
|
|
|
|
|
|||
|
Blood, 26 February 2009, Vol. 113, No. 9, pp. 2047-2055. Prepublished online as a Blood First Edition Paper on October 24, 2008; DOI 10.1182/blood-2008-05-160564.
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-41 Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO; and Departments of 2 Pathology and 3 Medicine, University of Colorado Denver Health Sciences
Chronic granulomatous disease (CGD) is characterized by overexuberant inflammation and autoimmunity that are attributed to deficient anti-inflammatory signaling. Although regulation of these processes is complex, phosphatidylserine (PS)–dependent recognition and removal of apoptotic cells (efferocytosis) by phagocytes are potently anti-inflammatory. Since macrophage phenotype also plays a beneficial role in resolution of inflammation, we hypothesized that impaired efferocytosis in CGD due to macrophage skewing contributes to enhanced inflammation. Here we demonstrate that efferocytosis by macrophages from CGD (gp91phox–/–) mice was suppressed ex vivo and in vivo. Alternative activation with interleukin 4 (IL-4) normalized CGD macrophage efferocytosis, whereas classical activation by lipopolysaccharide (LPS) plus interferon
Related Article in Blood Online:
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||